Marla Persky, Director at Xeris Biopharma Holdings, Inc. (XERS), sold 15,500 shares at $5.90 ($91K) on 2026-06-03, disclosed to the SEC on 2026-06-05.
Scheduled sale ($91k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CYTC | SELL | 2007-08-01 | $4.2M | — | Filing → |
| CYTC | SELL | 2006-02-21 | $398K | — | Filing → |